Viral Infections

  • Author: Jin S. Suh, MD, FACP (More Info)
  • Editors in Chief: Daniel R. Kuritzkes, MD; Joseph J. Eron, Jr., MD
  • Last Reviewed: 7/26/16 (What's New)

Summary

    Epidemiology
    • Although PML incidence has decreased significantly since the widespread use of ART, PML has been reported in HIV-infected patients with CD4+ cell counts > 300 cells/mm3 and as a complication of IRIS[Albrecht 1998; Ratnam 2006]
    Clinical Presentation
    • Clinical manifestations of PML vary depending on the area of the central nervous system involved, ranging from diffuse encephalopathy to focal deficits such as ataxia, hemiparesis, or speech difficulties
    • Rapid progression (weeks to months) is common
    Diagnosis
      Treatment
        Progressive Multifocal Leukoencephalopathy Prophylaxis

        Action required

        ©2018 Clinical Care Options, LLC. All Rights Reserved.

        The materials published via inPractice® reflect the views of the reviewers or authors of the material, not those of Clinical Care Options, LLC, the accredited provider, or the companies providing educational grants. The materials may discuss uses and dosages for therapeutic products that have not been approved by the United States Food and Drug Administration. A qualified healthcare professional should be consulted before using any therapeutic product discussed. Readers should verify all information and data before treating patients or using any therapies described in these materials.